Form 8-K - Current report:
SEC Accession No. 0001999480-24-000040
Filing Date
2024-11-12
Accepted
2024-11-12 16:20:08
Documents
14
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alto-20241112.htm   iXBRL 8-K 26804
2 EX-99.1 exhibit991-earningsrelease.htm EX-99.1 78174
  Complete submission text file 0001999480-24-000040.txt   243838

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20241112.xsd EX-101.SCH 1809
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20241112_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20241112_pre.xml EX-101.PRE 13061
16 EXTRACTED XBRL INSTANCE DOCUMENT alto-20241112_htm.xml XML 2923
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 241448554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)